首页 | 本学科首页   官方微博 | 高级检索  
     

肉毒毒素治疗肌张力障碍疾病138例疗效观察
引用本文:杨新玲,丁兴国,翁建英,马建华. 肉毒毒素治疗肌张力障碍疾病138例疗效观察[J]. 新疆医科大学学报, 2002, 25(1): 69-71
作者姓名:杨新玲  丁兴国  翁建英  马建华
作者单位:新疆医科大学第一附属医院神经内科,新疆 乌鲁木齐 830054
摘    要:目的:观察肉毒毒素治疗肌张力障碍疾病的临床疗效。方法:对68例偏侧面肌痉挛(HFS),50例眼睑痉挛(BS),17例Meige综合征。3例痉挛性斜颈进行面颈部肌肉局部多点注射A型肉毒毒素治疗,评价其治疗效果并观察其主要不良反应。结果:68例HFS完全缓解23例(34%),明显缓解41例(60%),部分缓解4例(6%),有效率达100%。50例BS完全缓解22例(44%),明显缓解26例(52%),部分缓解2例(12%),有效率达100%。17例Meige综合征完全缓解6例(35%),明显缓解9例(53%),部分缓解2例(12%),有效率达100%。3例痉挛性斜颈,2例部分性缓解,1例无效,起效时间平均3d,缓解维持时间平均9个月,局部副作用轻微、短暂且无明显全身反应及过敏反应。结论:用A型肉毒毒素治疗肌张力障碍局限性肌肉痉挛,是一种有效、副作用少、操作简便易行的治疗方法。

关 键 词:A型肉毒毒素 面肌痉挛 眼睑痉挛 Meige综合征 痉挛性斜颈
文章编号:1009-5551(2002)01-0069-03
修稿时间:2001-10-30

An observation of the efficancy by injection of botulinum toxin type A in the treatment of 138 cases in dystonia
YANG Xin-ling,DING Xin-guo,WENG Jian-yin,et al. An observation of the efficancy by injection of botulinum toxin type A in the treatment of 138 cases in dystonia[J]. Journal of Xinjiang Medical University, 2002, 25(1): 69-71
Authors:YANG Xin-ling  DING Xin-guo  WENG Jian-yin  et al
Abstract:Objective: To study the efficacy of the injection of botulinum toxin type A made in China (CBTX-A) for the treatment of hemifacial spasm (HFS), blepharospasm (BS), Meige's sydorme and spasmodic torticollis (CD). Method: 68 cases with HFS, 50 cases with BS, 17 cases with Meige's syndrome and 3 cases with CD were evaluated on therapeutic efficancy of multifocal facial injection and the main side effects that caused by the method of therapy were observed. Results: Of the 68 cases with HFS, 23(34%) patients were completely relieved, 41(60%) cases remarkably relieved, 4(6%) cases partially relieved; all of the patients experienced relief from spasm. Of the 50 patients with BS, 22(44%) were completely relieved, 26(52%) cases remarkably relieved, 2(4%) partially relieved, the effective rate was 100%. Of the 17 cases with Meige's syndrome, 6(35%) were completely relieved, 9(53%) were remarkably relieved, 2(12%) partially relieved, the effective rate was also 100%. Of 3 cases with CD, 2 cases were partially relieved, one was in vain. Observation showed that the time for marked improvement in symptoms after injection was average 3 days and lasted 9 months. The local side effects were transient and mild, no systemic adverse and allergic reaction were noted. Conclusion: The injection of CBTX-A for treatment of dystonia is effective and simple, at the same time, the side effects are very low.
Keywords:botulinum toxin type A  hemifacial spasm  blepharospasm  Meige's syndrome  spasmodic torricollis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号